摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-甲氧基-1H-吡咯并[3,2-b]吡啶-2-羧醛 | 17288-50-5

中文名称
5-甲氧基-1H-吡咯并[3,2-b]吡啶-2-羧醛
中文别名
5-甲氧基-2-醛基-4-氮杂吲哚
英文名称
2-formyl-5-methoxy-4-azaindole
英文别名
5-methoxy-1H-pyrrolo[3,2-b]pyridine-2-carbaldehyde;2-Formyl-5-methoxy-4-aza-indol;5-Methoxy-1H-pyrrolo[3,2-b]pyridine-2-carbaldehyde
5-甲氧基-1H-吡咯并[3,2-b]吡啶-2-羧醛化学式
CAS
17288-50-5
化学式
C9H8N2O2
mdl
MFCD08448191
分子量
176.175
InChiKey
CRYWKVXCWDXHPQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    363.3±37.0 °C(Predicted)
  • 密度:
    1.347±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    13
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.111
  • 拓扑面积:
    55
  • 氢给体数:
    1
  • 氢受体数:
    3

SDS

SDS:d4f06b1e307f1434fb0de599d9a5e4d6
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Structure and activity relationship of 2-(substituted benzoyl)-hydroxyindoles as novel CaMKII inhibitors
    摘要:
    A series of novel 2-substituted-5-hydroxyindoles were synthesized and evaluated for their inhibitory activity against CaMKII. Structure and activity relationship results indicated that potent inhibitory activity could be achieved by modification at the para-position of the phenyl ring of the high throughput screening hit compound 2. Among the prepared compounds, we identified 14 as a novel CaMKII inhibitor with an activity stronger than that of KN-93, a known CaMKII inhibitor. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2011.01.012
点击查看最新优质反应信息

文献信息

  • (5-MEMBERED)-(5-MEMBERED) OR (5-MEMBERED)-(6-MEMBERED) FUSED RING CYCLOALKYLAMINE DERIVATIVE
    申请人:MSD K.K.
    公开号:EP2319841A1
    公开(公告)日:2011-05-11
    Disclosed are a compound of a formula (I) and its pharmaceutically-acceptable salt: wherein Q is CH or N; R1a, R1b, R1c and R1d are independently a C1-6 alkyl, a halo-C1-6 alkyl, etc.; R2 is a hydrogen atom, etc.; R3 is independently a hydrogen atom, a C1-6 alkyl, etc., or two R3'S, taken together, form a bridge such as methylene, etc.; R4 and R4b are independently a hydrogen atom, a C1-6 alkyl, etc.; Z is a bicyclic aromatic hetero ring, etc.; Ar is a benzene ring, etc.; m1 and m2 are independently 0, 1 or 2; n is an integer of from 1 to 4. The compound and its salt act as a melanin concentrating hormone receptor antagonist, and are useful as a preventive or remedy for central system disorders, cardiovascular disorders, metabolic disorders, etc.
    本发明公开了一种具有化学式(I)及其药用可接受盐的化合物:其中Q为CH或N;R1a、R1b、R1c和R1d独立地为C1-6烷基、卤代C1-6烷基等;R2为氢原子等;R3独立地为氢原子、C1-6烷基等,或两个R3'结合在一起形成例如亚甲基等的桥;R4和R4b独立地为氢原子、C1-6烷基等;Z为双环芳香杂环、等;Ar为苯环等;m1和m2独立地为0、1或2;n为1至4的整数。该化合物及其盐作为黑色素浓集激素受体拮抗剂,并且可用作中枢系统紊乱、心血管紊乱、代谢紊乱等的预防或治疗。
  • Synthesis and Chemical Reactivity of 5-Methoxy-2-vinyl-4-azaindoles
    作者:Lourdes Rodriguez-Salvador、Elena Zaballos-Garcia、Eugenia Gonzalez-Rosende、Mohamed Djebouri Sidi、José Sepúlveda-Arques、R. Alan Jones
    DOI:10.1080/00397919708006075
    日期:1997.4
    Abstract 2-Vinyl-4-azaindoles are less reactive with dienophiles than 2-vinylindoles. 5-Methoxy-2-vinyl-4-azaindole 2a and its 1-methyl derivative 2a reacts with N-phenylmaleimide to yield cycloadducts only under vigorous conditions. 2b produces a cycloadduct with dimethyl acetylenedicarboxylate, while 2a yields a Michael-type adduct. Reactions with more reactive dienophiles gave only polymeric products.
    摘要 2-乙烯基-4-氮杂吲哚与亲二烯体的反应性低于2-乙烯基吲哚。5-Methoxy-2-vinyl-4-azaindole 2a 及其 1-甲基衍生物 2a 仅在剧烈条件下与 N-苯基马来酰亚胺反应生成环加合物。2b 与乙炔二羧酸二甲酯生成环加合物,而 2a 生成迈克尔型加合物。与更具反应性的亲双烯体的反应仅产生聚合产物。
  • 5/5-OR 5/6-MEMBERED CONDENSED RING CYCLOALKYLAMINE DERIVATIVE
    申请人:Kishino Hiroyuki
    公开号:US20110124674A1
    公开(公告)日:2011-05-26
    Disclosed are a compound of a formula (I) and its pharmaceutically-acceptable salt: wherein Q is CH or N; R 1a , R 1b , R 1c and R 1d are independently a C 1-6 alkyl, a halo-C 1-6 alkyl, etc.; R 2 is a hydrogen atom, etc.; R 3 is independently a hydrogen atom, a C 1-6 alkyl, etc., or two R 3 's, taken together, form a bridge such as methylene, etc.; R 4a and R 4b are independently a hydrogen atom, a C 1-6 alkyl, etc.; Z is a bicyclic aromatic hetero ring, etc.; Ar is a benzene ring, etc.; m1 and m2 are independently 0, 1 or 2; n is an integer of from 1 to 4. The compound and its salt act as a melanin concentrating hormone receptor antagonist, and are useful as a preventive or remedy for central system disorders, cardiovascular disorders, metabolic disorders, etc.
    本发明公开了一种化合物及其药学上可接受的盐,其化学式为(I): 其中,Q是CH或N;R1a,R1b,R1c和R1d独立地表示C1-6烷基,卤代C1-6烷基等;R2是氢原子等;R3独立地表示氢原子,C1-6烷基等,或者两个R3共同形成例如亚甲基等的桥;R4a和R4b独立地表示氢原子,C1-6烷基等;Z是双环芳香杂环,等;Ar是苯环等;m1和m2独立地表示0、1或2;n是1至4的整数。该化合物及其盐作为黑色素浓集激素受体拮抗剂,可用于预防或治疗中枢系统疾病、心血管疾病、代谢性疾病等。
  • INHIBITORS OF APOL1 AND METHODS OF USING SAME
    申请人:Vertex Pharmaceuticals Incorporated
    公开号:US20220106327A1
    公开(公告)日:2022-04-07
    The disclosure provides at least one entity chosen from compounds of Formula I, a tautomer thereof, a deuterated derivative of that compound or tautomer, and a pharmaceutically acceptable salt of any of the foregoing, compositions comprising the same, and methods of using the same, including uses in treating APOL1-mediated diseases, including pancreatic cancer, focal segmental glomerulosclerosis (FSGS), and/or non-diabetic kidney disease (NDKD).
  • [EN] (5-MEMBERED)-(5-MEMBERED) OR (5-MEMBERED)-(6-MEMBERED) FUSED RING CYCLOALKYLAMINE DERIVATIVE<br/>[FR] DÉRIVÉ DE CYCLOALKYLAMINE À NOYAUX FUSIONNÉS À (5 CHAÎNONS)-(5 CHAÎNONS) OU (5 CHAÎNONS)-(6 CHAÎNONS)
    申请人:BANYU PHARMA CO LTD
    公开号:WO2010013595A1
    公开(公告)日:2010-02-04
    【課題】 中枢性疾患、循環器系疾患、代謝性疾患用の医薬品として有用な、メラニン凝集ホルモン受容体の拮抗剤を提供することを目的とする。 【解決手段】 式(I) 【化1】[式中、Qは、CH又はNを表し、R1a、R1b、R1c及びR1dは、それぞれ独立して、C1-6アルキル、ハロC1-6アルキル等を表し、R2は、水素原子等を表し、R3は、それぞれ独立して、水素原子、C1-6アルキル等を表すか、2つのR3が一緒になって、メチレン等のブリッジを形成し、R4a及びR4bは、それぞれ独立して、水素原子、C1-6アルキル等を表し、Zは、2環性芳香族複素環等を表し、Arは、ベンゼン環等を表し、m1及びm2は、独立して、0、1又は2を表し、nは、1~4の整数を表す]で表される化合物又は薬学的に許容されるその塩。
查看更多

同类化合物

(4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 骆驼蓬酸 顺-六氢-1H-吡咯并[3,2-B]吡啶-4(2H)-羧酸叔丁基酯 螺哌啶-4,3’-3H吡咯并[2,3-b]吡啶-2’(1’H)-酮 螺[哌啶-4,3'-吡咯并[2,3-B]吡啶]-2'(1'H)-酮盐酸盐 莫西沙星杂质69 苹果酸法米替尼 苯乙胺,a,4-二甲基-b-苯基- 苄基-11氢吡咯并[3,4-B]吡啶 罗沙布林 甲基6-甲酰基-1-甲基-1H-吡咯并[3,2-b]吡啶-2-羧酸酯 甲基5-氰基-1H-吡咯并[2,3-b]吡啶-2-羧酸酯 甲基1H-吡咯并[2,3-B]吡啶-5-甲酸酯 甲基-1-甲氧基-4-吡咯并[3,2-c]吡啶 甲基 5-硝基-1H-吡咯并[2,3-B]吡啶-2-羧酸 环戊二烯并[4,5]吡咯并[2,3-B]吡啶,5,6,7,8-四氢 氧代-(1H-吡咯并[2,3-b]吡啶-3-基)-乙酸甲酯 培西达替尼盐酸盐 培西达替尼 吲嗪 吲哚嗪-6-羧酸乙酯 吲哚嗪-3-甲腈 吲哚嗪-2-羧酸甲酯 吲哚嗪-2-羧酸 叔丁基八氢-1H-吡咯并[2,3-c]吡啶-6-羧酸盐 叔丁基5-溴-7-氯-3-碘-1H-吡咯并[2,3-c]吡啶-1-羧酸盐 叔丁基5-溴-7-氯-1H-吡咯并[2,3-c]吡啶-1-羧酸盐 叔丁基3-甲酰基-5-甲基-1H-吡咯并[2,3-b]吡啶-1-羧酸盐 叔丁基3-(3-羟丙基-1-炔基)-5-甲基-1H-吡咯并[2,3-b]吡啶-1-羧酸盐 叔丁基(5-甲基-1H-吡咯并[2,3-b]吡啶-3-基)氨基甲酸酯 叔丁基((5-氟代-1H-吡咯并[2,3-b]吡啶-4-基)甲基氨基甲酸酯 反式-六氢-1H-吡咯并[3,4-C]吡啶-5(6H)-羧酸叔丁酯 化合物 T28221 八氢吡咯并[3.4-b]吡啶-1-羧酸叔丁酯 八氢吡咯并[3,4-b]吡啶 八氢-吡咯[3,4-C]吡啶-2-甲酸叔丁酯 八氢-6-(苯基甲基)-1H-吡咯并[3,4-b]吡啶-1-羧酸 1,1-二甲基乙酯 八氢-1H-吡咯并[3,4-C]吡啶 二苯基(吡咯并[2,3-b]吡啶-1-基)膦 二乙基1H-吡咯并[2,3B]吡啶-2,6-二甲酸基酯 乙基7-氯-3-甲基-1H-吡咯并[3,2-b]吡啶-2-甲酸基酯 乙基7-氮杂吲哚-4-羧酸酯 乙基4-(4,4,5,5-四甲基-1,3,2-二氧杂环戊硼烷-2-基)-1H-吡咯并[2,3-b]吡啶-2-羧酸酯 乙基3-氨基-2-吲嗪羧酸酯 乙基1-乙基-1H-吡咯并[3,2-c]吡啶-6-羧酸酯 中氮茚-7-羧酸甲酯 中氮茚-6-羧酸 中氮茚-1-甲酸甲酯 中氮茚-1-甲酸 中氮茚,1-[[4-(3-溴丙氧基)苯基]磺酰]-2-乙基-